TGFβ in Pancreas and Colorectal Cancer: Opportunities to Overcome Therapeutic Resistance

0
40
Scientists review the current TGFβ inhibitor drugs in clinical trials for pancreatic and colorectal cancer, with the goal of uncovering advances in improving clinical efficacy for TGFβ combinational treatments in patients.
[Clinical Cancer Research]
Abstract